COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 102: Articles 1011-1020  | Next

Change in mental health trends in Scotland, UK pre- and post-COVID-19
Cooke, E. A., Lemanska, A., Thomas, S. A.
10.1101/2024.12.16.24319095 — Posted: 2024-12-16
Highly recurrent multi-nucleotide mutations in SARS-CoV-2
De Maio, N., Smith, K., Turakhia, Y., Goldman, N.
10.1101/2024.12.14.628346 — Posted: 2024-12-16
A novel SARS-CoV-2-derived infectious vector system
Elfayres, G., Xiao, Y., Pan, Q., Liang, C., Barbeau, B., Berthoux, L.
10.1101/2024.12.16.628561 — Posted: 2024-12-16
Hamsters with long Covid exhibits a neurodegenerative signature in the brainstem
Coleon, A., Larrous, F., Kergoat, L., Tichit, M., Hardy, D., Obadia, T., Kornobis, E., Bourhy, H., de Melo, G. D.
10.1101/2024.12.16.628627 — Posted: 2024-12-16
ConvMut: A Web tool to analyze viral convergent mutations along phylogenies
Bernasconi, A., Fanfoni, E., Alfonsi, T., Focosi, D.
10.1101/2024.12.16.628620 — Posted: 2024-12-16
Safety, tolerability and clinical effects of BC007 on fatigue and quality of life in patients with post-COVID syndrome (reCOVer): a prospective, exploratory, randomised , placebo-controlled, double-blind, crossover phase IIa clinical trial
Hohberger, B., Ganslmayer, M., Harrer, T., Kruse, F., Maas, S., Borst, T., Heimke-Brinck, R., Stog, A., Knauer, T., Ruehl, E., Zeisberg, V., Skornia, A., Bartsch, A., Stroebel, A., Wytopil, M., Merkel, C., Hofmann, S., Schmidt, K. G., Lakatos, P., Schottenhamml, J., Herrmann, M., Mardin, C., Rech, J.
10.1101/2024.12.13.24318856 — Posted: 2024-12-14
Cost-utility analysis of current COVID-19 vaccination program recommendations in Canada
Simmons, A. E., Miranda, R. N., Li, M. W. Z., Gebretekle, G. B., Xi, M., Salvadori, M. I., Warshawsky, B., Wong, E., Ximenes, R., Andrew, M. K., Wilson, S., Tunis, M., Tuite, A. R.
10.1101/2024.12.13.24318988 — Posted: 2024-12-14
Evaluation of T Cell Immune Memory Response after Sinopharm (BBIBP-CorV), Gam-COVID-Vac (Sputnik-V), and Heterologous Sputnik-V/mRNA-1273 (Moderna) COVID-19 Vaccination Schemes against Different SARS-CoV-2 Variants.
Pereson, M. J., Badano, M. N., Sabbione, F., Keitelman, I., Aloisi, N., Fink, S., Amaya, L., Garcia, G., Martinez, A., Di Lello, F. A., Bare, P.
10.1101/2024.12.13.24318016 — Posted: 2024-12-14
Subjective experience of women with childbirth in hospitals after COVID-19 outbreak: Insights from Babies Born Better survey
Greskovicova, K., Nemcova, M., Sikova, T.
10.1101/2024.12.12.24318966 — Posted: 2024-12-14
Estimating changes in life expectancy in Hong Kong during the COVID-19 pandemic
Law, A. H. T., Presanis, A. M., Cheung, J. K., Wu, P., Schooling, M., Cowling, B. J., Wong, J. Y.
10.1101/2024.12.12.24318910 — Posted: 2024-12-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).